Canada· CA-DIN-02172755

OMNIPAQUE 350

A iohexol product containing iohexol, registered in Canada by GE HEALTHCARE CANADA INC. The same ATC class is registered in 17 of our 19 countries.

ATC V08AB02

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about iohexolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Iohexol is registered in 17 of 19 countries.

Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
9 of them publish a price we can compare per daily dose

Search iohexol products by name

Iohexol · ATC V08AB02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: IOHEXOL
Manufacturer: GE HEALTHCARE CANADA INC
Country: Canada (CA)
ATC code: V08AB02
ATC class: Iohexol
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

353 interactions on record for iohexol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check iohexol against other medicines How interaction checks work

Iohexol · interactions on record

353 records

286 severe
54 moderate
13 info

Most severe, free to view

MetoclopramideA03FA01severe
ThiethylperazinA04AB03severe
TriflupromazinA04AD06severe
DronabinolA04AD10severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iohexol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iohexol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Accupaque, Iovision
Belgium · Omnipaque
Bulgaria · Kopaq, Контамедиа Йох
Cyprus · Omnipaque
Czechia · Omnipaque
Germany · Accupaque, Iovision
Estonia · Iohexol Imax, Omnipaque
Spain · Omnipaque
Finland · Omnipaque
France · Omnipaque
United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
Greece · Omnipaque
Croatia · Omnipaque
Hungary · Iohexol Wogen, Omnipaque
Ireland · Omnipaque
Iceland · Omnipaque
Italy · Omnipaque
Lithuania · Iohexol Icg Farma, Iohexol Imax
Luxembourg · Omnipaque
Latvia · Iohexol Imax, Omnipaque
Malta · Omnipaque
Netherlands · Iohexol Adoh, Omnipaque
Norway · Omnipaque
Poland · Omnipaque
Portugal · Iohexol Imax, Omnipaque
Romania · Omnipaque
Sweden · Iovision, Omnipaque
Slovenia · Omnipaque
Slovakia · Omnipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c2c6f264-e67c-4ff3-bb2d-e74bacc0f3f0
GET /v1/drugs/c2c6f264-e67c-4ff3-bb2d-e74bacc0f3f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02172755",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVASCULAR",
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V08AB02",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "44187",
  "strengths": [
    "755 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "IOHEXOL"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about iohexol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console